These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 17947715

  • 1. Obesity in dose calculation: a mouse or an elephant?
    Gurney H, Shaw R.
    J Clin Oncol; 2007 Oct 20; 25(30):4703-4. PubMed ID: 17947715
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese.
    Sparreboom A, Wolff AC, Mathijssen RH, Chatelut E, Rowinsky EK, Verweij J, Baker SD.
    J Clin Oncol; 2007 Oct 20; 25(30):4707-13. PubMed ID: 17947717
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of doxorubicin and etoposide in a morbidly obese pediatric patient.
    Ritzmo C, Söderhäll S, Karlén J, Nygren H, Eksborg S.
    Pediatr Hematol Oncol; 2007 Sep 20; 24(6):437-45. PubMed ID: 17710661
    [Abstract] [Full Text] [Related]

  • 4. Influence of lean body weight on anticancer drug clearance.
    Mathijssen RH, Sparreboom A.
    Clin Pharmacol Ther; 2009 Jan 20; 85(1):23; author reply 24. PubMed ID: 18288084
    [No Abstract] [Full Text] [Related]

  • 5. [Anticancer drugs pharmacokinetics update].
    Canal P, Gautié L, Grégoire N, Perdaems N, Chatelut E.
    Bull Cancer; 1999 Jan 20; 86(1):85-9. PubMed ID: 10029710
    [No Abstract] [Full Text] [Related]

  • 6. [Drug dosing in overweight and underweight].
    Raknes G, Schjøtt JD.
    Tidsskr Nor Laegeforen; 2008 Aug 28; 128(16):1843-4. PubMed ID: 18787597
    [No Abstract] [Full Text] [Related]

  • 7. Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.
    Schwartz J, Toste B, Dizon DS.
    Gynecol Oncol; 2009 Jul 28; 114(1):53-6. PubMed ID: 19359030
    [Abstract] [Full Text] [Related]

  • 8. Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men.
    Rosengren A, Hauptman PJ, Lappas G, Olsson L, Wilhelmsen L, Swedberg K.
    Eur Heart J; 2009 May 28; 30(9):1113-20. PubMed ID: 19304990
    [Abstract] [Full Text] [Related]

  • 9. A combined Body Surface Area and Body Mass Index nomogram.
    Selzer R, Logan P, Bowes G, Patton G.
    J Paediatr Child Health; 1994 Aug 28; 30(4):375-6. PubMed ID: 7946562
    [No Abstract] [Full Text] [Related]

  • 10. Carboplatin dosing in obese women with ovarian cancer: a Gynecologic Oncology Group study.
    Wright JD, Tian C, Mutch DG, Herzog TJ, Nagao S, Fujiwara K, Powell MA.
    Gynecol Oncol; 2008 Jun 28; 109(3):353-8. PubMed ID: 18407341
    [Abstract] [Full Text] [Related]

  • 11. A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.
    Schmitt A, Gladieff L, Lansiaux A, Bobin-Dubigeon C, Etienne-Grimaldi MC, Boisdron-Celle M, Serre-Debauvais F, Pinguet F, Floquet A, Billaud E, Le Guellec C, Penel N, Campone M, Largillier R, Capitain O, Fabbro M, Houede N, Medioni J, Bougnoux P, Lochon I, Chatelut E.
    Clin Cancer Res; 2009 May 15; 15(10):3633-9. PubMed ID: 19401344
    [Abstract] [Full Text] [Related]

  • 12. Challenges of accurately measuring and using BMI and other indicators of obesity in children.
    Himes JH.
    Pediatrics; 2009 Sep 15; 124 Suppl 1():S3-22. PubMed ID: 19720665
    [Abstract] [Full Text] [Related]

  • 13. Re: "Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the women's health initiative (United States)".
    Sharifi N, Farrar WL.
    Am J Epidemiol; 2008 Apr 15; 167(8):1016; author reply 1016. PubMed ID: 18344511
    [No Abstract] [Full Text] [Related]

  • 14. Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points.
    Majed B, Moreau T, Asselain B, Curie Institute Breast Cancer Group.
    Breast Cancer Res Treat; 2009 May 15; 115(1):193-203. PubMed ID: 18546073
    [Abstract] [Full Text] [Related]

  • 15. Comparison of BMI and the body mass/body surface ratio: is BMI a biased tool?
    Kurbel S, Zucić D, Vrbanec D, Plestina S.
    Coll Antropol; 2008 Mar 15; 32(1):299-301. PubMed ID: 18494217
    [Abstract] [Full Text] [Related]

  • 16. Differentiating between body fat and lean mass--how should we measure obesity?
    Szabó T, von Haehling S, Doehner W.
    Nat Clin Pract Endocrinol Metab; 2008 Nov 15; 4(11):E1; author reply E2. PubMed ID: 18946485
    [No Abstract] [Full Text] [Related]

  • 17. Obesity: the current treatment protocols.
    Boissonneault GA, Clinical and Scientific Affairs Council of the AAPA.
    JAAPA; 2009 Jan 15; 22(1):16, 18-9. PubMed ID: 19248355
    [No Abstract] [Full Text] [Related]

  • 18. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
    Costa LJ, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Litzow MR, Ansell SM.
    Br J Haematol; 2008 Oct 15; 143(2):268-73. PubMed ID: 18699848
    [Abstract] [Full Text] [Related]

  • 19. Anthropometric, metabolic, psychosocial, and dietary characteristics of overweight/obese postmenopausal women with a history of weight cycling: a MONET (Montreal Ottawa New Emerging Team) study.
    Strychar I, Lavoie ME, Messier L, Karelis AD, Doucet E, Prud'homme D, Fontaine J, Rabasa-Lhoret R.
    J Am Diet Assoc; 2009 Apr 15; 109(4):718-24. PubMed ID: 19328269
    [Abstract] [Full Text] [Related]

  • 20. Anesthetizing the obese.
    Green B, McLeay SC.
    Anesth Analg; 2011 Jul 15; 113(1):1-3. PubMed ID: 21700690
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.